Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMorgan Sindall Group Regulatory News (MGNS)

Share Price Information for Morgan Sindall Group (MGNS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,565.00
Bid: 2,575.00
Ask: 2,585.00
Change: -20.00 (-0.77%)
Spread: 10.00 (0.388%)
Open: 2,590.00
High: 2,590.00
Low: 2,560.00
Prev. Close: 2,585.00
MGNS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Muse Developments appointed preferred bidder

7 May 2013 09:00

RNS Number : 0362E
Morgan Sindall Group PLC
07 May 2013
 



7 May 2013

MORGAN SINDALL GROUP PLC

Muse Developments appointed preferred bidder for redevelopment of St Nicholas House,

former Aberdeen City Council HQ

Morgan Sindall Group plc announces that Muse Developments, its Urban Regeneration division, in joint venture with Aviva Investors, has been appointed as preferred bidder to work with Aberdeen City Council on the redevelopment of the St Nicholas House site in Aberdeen. The project will be fully funded by Aviva Investors, and has an overall value in excess of £100m.

Muse Developments proposes to develop a vibrant new mixed-use quarter for the city on the brownfield site which previously housed the local authority's corporate headquarters. The proposal is for a development which will house offices, a boutique hotel, cafés, restaurants and retail space, as well as creating a significant amount of public space including a small civic square and pedestrianising Broad Street. Provost Skene's House is also included in the proposals.

The Council will lease the development from Muse and receive a proportion of the rental profits for 35 years, after which the site and development will transfer into council ownership.

A public consultation lasting 12 weeks will be carried out before any planning application is submitted. The site will be developed in a single phase and Muse aims for completion during 2016.

John Morgan, Chief Executive of Morgan Sindall Group, commented: "Muse Developments is delighted with the opportunity of working on this scheme. We have a strong track record in similar joint venture regeneration projects and are confident that we will deliver a successful living and working destination. We are excited to be working with Aberdeen City Council and look forward to bringing innovation and long-term value for the people of Aberdeen."

ENDS

Editor's notes: 

Morgan Sindall Group plc

Morgan Sindall Group plc is a leading UK construction and regeneration group with a turnover of £2 billion, employing around 6,500 employees and operating in the public and commercial sectors. It operates through five divisions of construction and infrastructure, fit out, affordable housing, urban regeneration and investments.

Muse Developments

Muse Developments is one of the country's leading names in commercial development and urban regeneration. A national developer - with regional operations in Manchester, London, Leeds and Glasgow. It delivers complex mixed-use schemes - with the accent on quality and sustainability - and creates vibrant new places in towns and cities. Founded on the extensive experience of its management and delivery teams, Muse is driven by a desire to bring a fresh and innovative approach to property development. Muse is part of Morgan Sindall Group plc, a leading UK construction and regeneration group with revenue of over £2 billion and which operates through five divisions of construction and infrastructure, affordable housing, fit out, urban regeneration and investments.

 

ENQUIRIES:

 

Morgan Sindall Group plc Tel: 020 7307 9200

John Morgan, Chief Executive

Steve Crummett, Finance Director

 

 

 

Brunswick Tel: 0207 404 5959

Nina Coad

Alison Kay

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRANKNDBABKDAPK
Date   Source Headline
14th Jun 20239:13 amRNSHolding(s) in Company
12th Jun 20233:50 pmRNSHolding(s) in Company
1st Jun 20239:16 amRNSTotal Voting Rights
31st May 20234:10 pmRNSHolding(s) in Company
10th May 202311:19 amRNSAdditional Listing
5th May 20232:38 pmRNSHolding(s) in Company
4th May 202312:44 pmRNSResult of AGM
4th May 20237:00 amRNSTrading Update
20th Apr 202310:24 amRNSBlock listing Interim Review
23rd Mar 20231:51 pmRNSAnnual Financial Report
21st Mar 20234:24 pmRNSAdditional Listing
16th Mar 20233:34 pmRNSDirector/PDMR Shareholding
16th Mar 20231:52 pmRNSDirector/PDMR Shareholding
14th Mar 20237:00 amRNSUK Government Self Remediation Contract
13th Mar 20232:40 pmRNSDirector/PDMR Shareholding
3rd Mar 202311:58 amRNSDirector/PDMR Shareholding
3rd Mar 202311:57 amRNSDirector/PDMR Shareholding
2nd Mar 20234:42 pmRNSDirector/PDMR Shareholding
2nd Mar 20234:41 pmRNSDirector/PDMR Shareholding
1st Mar 202311:28 amRNSTotal Voting Rights
23rd Feb 20237:00 amRNSFinal Results
6th Feb 20237:00 amRNSNotice of Full Year Results
1st Feb 20231:04 pmRNSTotal Voting Rights
25th Jan 20232:59 pmRNSHolding(s) in Company
3rd Jan 20231:56 pmRNSTotal Voting Rights
12th Dec 20228:25 amRNSHolding(s) in Company
5th Dec 20223:37 pmRNSHolding(s) in Company
2nd Dec 20229:06 amRNSTotal Voting Rights
7th Nov 20224:08 pmRNSAGM Voting Update
2nd Nov 20227:00 amRNSTrading Update
1st Nov 20221:49 pmRNSTotal Voting Rights
20th Oct 202211:00 amRNSBlock listing Interim Review
18th Oct 20221:16 pmRNSAdditional Listing
3rd Oct 20221:51 pmRNSTotal Voting Rights
13th Sep 20223:27 pmRNSAdditional Listing
1st Sep 202210:43 amRNSTotal Voting Rights
19th Aug 202211:00 amRNSDirector/PDMR Shareholding
4th Aug 20227:00 amRNSHalf-year Report
1st Aug 202210:16 amRNSTotal Voting Rights
11th Jul 20227:00 amRNSNotice of Results
1st Jul 202210:50 amRNSTotal Voting Rights
14th Jun 202212:51 pmRNSAdditional Listing
6th Jun 202212:00 pmRNSTotal Voting Rights
1st Jun 20223:49 pmRNSDirector Declaration
17th May 20221:47 pmRNSHolding(s) in Company
10th May 202211:23 amRNSAdditional Listing
5th May 20224:45 pmRNSResult of AGM
5th May 20227:00 amRNSAGM Trading Update
3rd May 20223:48 pmRNSTotal Voting Rights
20th Apr 202210:25 amRNSBlock listing Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.